Researchers have recently increased their focus on the link between autoimmune diseases and infections. Most of the recent research indicates that silent human cytomegalovirus (HCMV), may have diverse roles in the initiation, development, and exacerbation of autoimmune diseases, such as coeliac Disease (CD) and inflammatory bowel disease. The aim of this study is to evaluate the role of HCMV infection in Iraqi patients with CD. Serum samples were obtained from 60 patients with CD, and from 60 healthy subjects. Enzyme-linked immunosorbent assay was used to determine the Anti-Transglutaminase IgG/IgA, Anti-gliadin IgA/ IgG, as well as the HCMV IgM/ IgG levels in the serum samples. Significantly higher percentage of positivity for serum Anti-transglutaminase (100% vs 0%. p=0.00), serum Anti-gliadin A (96.7% vs. 13.3%, p=0.00) and serum Anti-gliadin G (90% vs. 13.3%, p=0.00) in active CD patients from the healthy controls. Serum Anti-HCMV IgM were detected equally in (3.3%) among both in CD patients and controls whereas serum Anti-HCMV IgG in both CD patients and the controls were (76.7% vs.78.3% , p=0.827). The mean concentrations of studied specific antibodies for CD in patient’s serum are highly significant associated with positive anti-HCMV IgG compared to controls. HCMV infections could participate in the immunopathogenesis of CD whether it’s an autoimmune triggering factor, or may be coexist during immunosuppressive state of the disease, all of which can further worsen the disease prognosis. Further studies are needed in detail to understand HCMV immune-pathological effect and to develop new strategies for targeted therapeutic interventions.
___
1. Lerner A, Arleevskaya M, Schmiedl A, Matthias T. Microbes and Viruses Are Bugging the Gut in Celiac Disease. Are They Friends or Foes? Front Microbiol 2017; 8: 1392.
2. Anis S, Kumar R, Abbas Z, Hassan SM, Luck NH, Muzaffar R. Coeliac disease and multiple immunodeficiencies: case report of a diagnostic dilemma. J Pak Med Assoc 2012; 62: 730-732.
3. Chen A, Linz CM, Tsay JL, Jin M, El-Dika SS. Celiac Crisis Associated with Herpes Simplex Virus Esophagitis. ACG Case Rep J 2016; 3(4): e159-e.
4. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008; 5: 47.
5. Nikolich-Žugich J, van Lier RAW. Cytomegalovirus (CMV) research in immune senescence comes of age: overview of the 6th International Workshop on CMV and Immunosenescence. Geroscience 2017; 39: 245-249.
6. Chiereghin A, Potena L, Borgese L, Gibertoni D, Squarzoni D, Turello G, et al. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection. J Clin Microbiol 2018; 56: e01040-17.
7. Haese N, Burg J, Ando T, Jones I, Kreklywich C, Orloff S, et al. Depletion of macrophages from Cytomegalovirus (CMV) latently infected donor allografts decreases CMV mediated immunopathology and prevents CMV-accelerated chronic rejection. The Journal of Immunology 2018; 200: 55.25-55.25.
8. Kelly E, Cullen G, Aftab AR, Courtney G. Coeliac crisis presenting with cytomegalovirus hepatitis. European journal of gastroenterology & hepatology 2006; 18: 793-795.
9. Nemes E. Pathologic antibody responses in celiac disease: specificity and immunological correlations. PhD Thesis. University of Debrecen: Debrecen. 2008. Avaliable from: https://dea.lib.unideb.hu/dea/bitstream/handle/2437/31682/Nemes_Eva_tezis_angol.pdf?sequence=7&isAllowed=y
10. Plot L, Amital H, Barzilai O, Ram M, Nicola B, Shoenfeld Y. Infections May Have a Protective Role in the Etiopathogenesis of Celiac Disease. Annals of the New York Academy of Sciences 2009; 1173: 670-674.
11. Jansen MA, van den Heuvel D, van der Zwet KV, Jaddoe VW, Hofman A, Escher JC, et al. Herpesvirus Infections and Transglutaminase Type 2 Antibody Positivity in Childhood: The Generation R Study. Journal of pediatric gastroenterology and nutrition 2016; 63: 423-430.
12. CDC. Cytomegalovirus (CMV) and congenital CMV infection, Centers for Disease Control and Prevention. 2020. Available from: https://www.cdc.gov/cmv/clinical/lab-tests.html
13. Ross SA, Novak Z, Pati S, Boppana SB. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets 2011; 11: 466-474.
14. Brown JJ, Jabri B, Dermody TS. A viral trigger for celiac disease. PLoS Pathog 2018; 14:e1007181-e.
15. Halenius A, Hengel H. Human cytomegalovirus and autoimmune disease. BioMed research international 2014; 2014: 472978.
16. Kaufman HS, Kahn AC, Iacobuzio-Donahue C, Talamini MA, Lillemoe KD, Hamilton SR. Cytomegaloviral enterocolitis: clinical associations and outcome. Diseases of the colon and rectum 1999; 42: 24-30.
17. You DM, Johnson MD. Cytomegalovirus infection and the gastrointestinal tract. Current gastroenterology reports 2012; 14: 334-342.
18. Weinberg A, Bosch R, Bennett K, Tovar-Salazar A, Benson CA, Collier AC, et al. Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS. Journal of acquired immune deficiency syndromes 2014; 66: 25-32. Epub 2014/01/01.
19. Lebwohl B, Blaser MJ, Ludvigsson JF, Green PHR, Rundle A, Sonnenberg A, et al. Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol 2013; 178: 1721-1730.
20. Muhsin JM. Study the possible Seropositivity connection of EBV, Rubella Virus & CMV infection with four groups of autoimmune diseases in sample of Iraqi patients. Al-Nisour Journal for Medical Sciences 2019; 1: 108-117.
21. Perfetti V, Baldanti F, Lenti MV, Vanoli A, Biagi F, Gatti M, et al. Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2016; 14: 1216-1220.
22. Dolcino M, Zanoni G, Bason C, Tinazzi E, Boccola E, Valletta E, et al. A subset of anti-rotavirus antibodies directed against the viral protein VP7 predicts the onset of celiac disease and induces typical features of the disease in the intestinal epithelial cell line T84. Immunologic research 2013; 56: 465-76.
23. Nylund L, Kaukinen K, Lindfors K. The microbiota as a component of the celiac disease and non-celiac gluten sensitivity. Clinical Nutrition Experimental 2016; 6: 17-24.
24. Vermeersch P, Geboes K, Marien G, Hoffman I, Hiele M, Bossuyt X. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease. Clinica chimica acta; international journal of clinical chemistry 2010; 411: 931-935.
25. Bragde H, Jansson U, Fredrikson M, Grodzinsky E, Soderman J. Potential blood-based markers of celiac disease. BMC gastroenterology 2014; 14: 176.
26. Vives-Pi M, Takasawa S, Pujol-Autonell I, Planas R, Cabre E, Ojanguren I, et al. Biomarkers for diagnosis and monitoring of celiac disease. Journal of clinical gastroenterology 2013; 47: 308-313.
27. Clouzeau-Girard H, Rebouissoux L, Taupin JL, Le Bail B, Kalach N, Michaud L, et al. HLA-DQ genotyping combined with serological markers for the diagnosis of celiac disease: is intestinal biopsy still mandatory? Journal of pediatric gastroenterology and nutrition 2011; 52: 729-33.
28. Planas R, Pujol-Autonell I, Ruiz E, Montraveta M, Cabre E, Lucas-Martin A, et al. Regenerating gene Ialpha is a biomarker for diagnosis and monitoring of celiac disease: a preliminary study. Translational research : the journal of laboratory and clinical medicine 2011; 158: 140-145.
29. Tsuchida C, Sakuramoto-Tsuchida S, Taked M, Itaya-Hironaka A, Yamauchi A, Misu M, et al. Expression of REG family genes in human inflammatory bowel diseases and its regulation. Biochemistry and biophysics reports 2017; 12: 198-205.